Is Bal Pharma Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Bal Pharma Ltd (BALPHARMA.NS) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Bal Pharma Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Bal Pharma Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Bal Pharma Ltd?

Muslim investors may consider investing in Bal Pharma Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Bal Pharma Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Bal Pharma Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Bal Pharma Ltd updated?

The Shariah compliance status of Bal Pharma Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Bal Pharma Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Bal Pharma Ltd?

You can check the latest Shariah compliance status of Bal Pharma Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

BALPHARMA.NS Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: January 14, 2026

Report Source: 2026 2nd Quarter Report

Bal Pharma Ltd. Stock Analysis BALPHARMA.NS

India Health Care Nano Cap Report: Q2, 2026

Bal Pharma Ltd. is a holding company, which engages in the research, development, and commercialization of pharmaceutical products. The firm is engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients (API). The company specializes in prescription drugs, generic & OTC products, intravenous infusion, and bulk actives. The firm offers a range of APIs including antihistamine, platelet inhibitor, anti-diabetic, anticonvulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, acne treatment, and others. The company also offers a range of formulations covering dosage forms-tablets, capsules, syrups, suspensions, IV infusions, ophthalmics, creams and ointments to various semi-regulated markets. The API products are being exported to Japan, Australia, Spain, the United Kingdom, Canada, Nigeria, Iceland, Slovenia, Romania, Brazil, Pakistan, Germany, South Africa, Serbia, Taiwan, Malaysia, Thailand, among others.

Key Statistics of Bal Pharma Ltd (BALPHARMA.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹78.00₹82.44

Today's Open

₹78.00

Volume

7671.00

P/E Ratio (TTM)

17.43

52 Week Range

₹60.00₹111.18

Market Cap

1.20B

Avg. Volume

14.96K

Dividend Yield

1.52%

Financial Metrics & Statements of Bal Pharma Ltd (BALPHARMA.NS)

FAQ's for Bal Pharma Ltd (BALPHARMA.NS)

According to Musaffa’s Shariah screening methodology, Bal Pharma Ltd (BALPHARMA.NS) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.